Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Virtra (VTSI) PT Raised to $12 at Maxim Group
-
Aridis Pharmaceuticals Inc. (ARDS) Prices 2M Share IPO at $13/Sh
-
Aridis Pharmaceuticals Announces Pricing of Initial Public Offering
-
Zoe's Kitchen (ZOES) PT Lowered to $10 at Maxim Group
-
Matinas BioPharma Holdings Inc. (MTNB) PT Lowered to $2 at Maxim Group
-
Ecoark Announces $4.75 Million Registered Direct Offering
-
Omeros Corp. (OMER) PT Raised to $32 at Maxim Group
-
I-ON Communications Corp. Announces the Appointment of Four New Independent Board Members and Opening of New U.S. Headquarters
-
BioLife Solutions (BLFS) PT Raised to $26 at Maxim Group
-
BeiGene, Ltd. (BGNE) PT Lowered to $215 at Maxim Group
-
SenesTech Announces Approximately $6.1 Million in Expected Gross Proceeds from Rights Offering
-
Biocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights Offering
-
Coherus Biosciences (CHRS) PT Raised to $25 at Maxim Group; Sees Transformative Q4
-
Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
-
ContraVir Pharma (CTRV) Announces Update to Business Activities
-
ContraVir Pharmaceuticals Provides an Update to Corporate Objectives
-
Aridis Pharmaceuticals Launches Proposed Initial Public Offering
-
New York Mortgage Trust (NYMT) PT Raised to $6.75 at Maxim Group
-
Maxim Group Downgrades Immune Pharmaceuticals (IMNP) to Hold CIting Financing Concerns
-
SenesTech, Inc. Announces Updated Pricing Terms of Rights Offering and Reminds Subscription Holders of August 8, 2018 Expiration Date
-
Tableau Software (DATA) PT Raised to $107 at Maxim Group
-
Maxim Group Downgrades Habit Restaurants (HABT) to Hold Citing Valuation
-
CytoSorbents (CTSO) PT Raised to $18 at Maxim Group
-
Maxim Group Starts Entera Bio (ENTX) at Buy
-
Adamis Pharmaceuticals (ADMP) Prices 11.67M Share Common Offering at $3/Sh
-
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Maxim Group Starts Capstone Turbine (CPST) at Buy
-
Chipotle slumps 9 percent after Ohio outlet linked to food poisoning complaints
-
Intevac (IVAC) Removes $6.50 PT on Maxim Group; Reiterates Hold Following 2Q
-
ADMA Biologics (ADMA) PT Raised to $12 at Maxim Group
-
UPDATE: Maxim Group Upgrades Cracker Barrel (CBRL) to Buy
-
Maxim Group Assumes Helios and Matheson Analytics (HMNY), Downgrades to Hold
-
Maxim Group Upgrades Eagle Bulk Shipping (EGLE) to Buy
-
Dolphin Entertainment Announces Closing Of $6.0 Million Public Offering Of Common Stock
-
Cytori Announces $6.7 Million in Expected Gross Proceeds from Recently Expired Rights Offering
-
TOP Ships Inc. Announces Termination of ATM Program and Other Corporate Developments
-
DineEquity (DIN) Added to Maxim Top Pick List
-
UPDATE: Darden (DRI)Removed From Maxim Top Pick List
-
Dave & Buster's Entertainment (PLAY) Added to Maxim Top Pick List
-
Dunkin' Brands (DNKN) Removed From Maxim Top Pick List
-
Dolphin Entertainment, Inc. (DLPN) Prices 2M Share Offering at $3/Sh
-
Dolphin Entertainment Announces Pricing Of $6.0 Million Public Offering Of Common Stock
-
SenesTech Reminds Investors of Today's Deadline to be a Shareholder of Record
-
Dolphin Entertainment, Inc. (DLPN) to Offer Common Stock
-
Dolphin Entertainment Announces Proposed Public Offering Of Common Stock
-
Priority Income Fund Successfully Invests Net Proceeds from Preferred Offering
-
Biocept Reminds Investors of Today's Deadline to be a Shareholder of Record
-
PlacementTracker Publishes First Half 2018 PIPE Market League Tables
-
Maxim Group Assumes IPass Inc. (IPAS) at Buy
-
Mesoblast Limited (MESO) PT Raised to $16 at Maxim Group

